Ceftaroline for Severe Methicillin-Resistant Staphylococcus aureus Infections: A Systematic Review

Ceftaroline is approved by the Food and Drug Administration for acute bacterial skin and skin-structure infections and community-acquired bacterial pneumonia, including cases with concurrent bacteremia. Use for serious methicillin-resistant Staphylococcus aureus (MRSA) infections has risen for a mul...

Descripción completa

Detalles Bibliográficos
Autores principales: Cosimi, Reese A., Beik, Nahal, Kubiak, David W., Johnson, Jennifer A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499876/
https://www.ncbi.nlm.nih.gov/pubmed/28702467
http://dx.doi.org/10.1093/ofid/ofx084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499876/
https://www.ncbi.nlm.nih.gov/pubmed/28702467
http://dx.doi.org/10.1093/ofid/ofx084

Ejemplares similares